Cargando…

2771. Seroprotection against Measles, Rubella, Tetanus, and Diphtheria Among Children in Haiti—2017

BACKGROUND: Measles, rubella, and maternal and neonatal tetanus have been verified to be eliminated in Haiti, but a diphtheria outbreak has been ongoing since 2014. To evaluate progress toward maintaining vaccine preventable disease (VPD) elimination and control, we conducted the first survey to est...

Descripción completa

Detalles Bibliográficos
Autores principales: Minta, Anna A, Andre-Alboth, Jocelyne, Childs, Lana, Nace, Doug, Rey-Benito, Gloria, Boncy, Jacques, Adrien, Paul, François, Jeannot, Jn Charles, Nadia Phaïmyr, Blot, Valery, Vanden Eng, Jodi L, Priest, Jeffrey W, Rogier, Eric, Tohme, Rania A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810738/
http://dx.doi.org/10.1093/ofid/ofz360.2448
_version_ 1783462317893091328
author Minta, Anna A
Andre-Alboth, Jocelyne
Childs, Lana
Nace, Doug
Rey-Benito, Gloria
Boncy, Jacques
Adrien, Paul
François, Jeannot
Jn Charles, Nadia Phaïmyr
Blot, Valery
Vanden Eng, Jodi L
Priest, Jeffrey W
Rogier, Eric
Tohme, Rania A
author_facet Minta, Anna A
Andre-Alboth, Jocelyne
Childs, Lana
Nace, Doug
Rey-Benito, Gloria
Boncy, Jacques
Adrien, Paul
François, Jeannot
Jn Charles, Nadia Phaïmyr
Blot, Valery
Vanden Eng, Jodi L
Priest, Jeffrey W
Rogier, Eric
Tohme, Rania A
author_sort Minta, Anna A
collection PubMed
description BACKGROUND: Measles, rubella, and maternal and neonatal tetanus have been verified to be eliminated in Haiti, but a diphtheria outbreak has been ongoing since 2014. To evaluate progress toward maintaining vaccine preventable disease (VPD) elimination and control, we conducted the first survey to estimate immunity to these VPDs among children in Haiti. METHODS: We conducted a nationally representative, two-stage cluster survey in 2017, stratifying Haiti into 2 regions: (1) West Region, the highly urban West department that includes one-third of Haiti’s population; (2) Non-West Region (all other departments). We sampled 4,286 households to recruit at least 910 children aged 5–7 years. We obtained vaccination history and dried blood spots from one eligible child per household. Antibody concentrations to VPDs were measured on a multiplex bead assay. We compared seroprotection and vaccination coverage estimates. RESULTS: Among 1146 enrolled children, tetanus (83%, 95% CI: 80%–86%) and diphtheria (83%, 95% CI: 81%–85%) seroprotection were higher than coverage with ≥3 doses of tetanus and diphtheria containing vaccine (DTP3) (68%, 95% CI: 61%–74%). No participants had antibody concentrations consistent with long-term immunity to tetanus or diphtheria. Measles (87%, 95% CI: 85%–89%) and rubella (84%, 95% CI: 81%–87%) seroprotection were higher than or similar to coverage with at least one dose of measles-rubella (MR) vaccine (84%, 95% CI: 80%–87%) (Figure 1). MR second-dose coverage was 20% (95% CI: 16%–24%). Seroprotection in the West Region was lower than in the non-West region for all VPDs. CONCLUSION: Discordance between DTP3 coverage and seroprotection might be due to underestimating vaccination coverage by recall. Lack of long-term protection against tetanus or diphtheria is consistent with declining antibody concentrations by school-age after the primary DTP series, indicating the need for a booster dose. Seroprotection against measles and rubella viruses was lower than levels needed to prevent transmission, particularly in the West region; re-introduction of either virus could lead to an epidemic. Haiti should reach ≥95% DTP3 and two-dose MR coverage and add tetanus and diphtheria vaccine booster doses per global recommendations. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810738
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68107382019-10-28 2771. Seroprotection against Measles, Rubella, Tetanus, and Diphtheria Among Children in Haiti—2017 Minta, Anna A Andre-Alboth, Jocelyne Childs, Lana Nace, Doug Rey-Benito, Gloria Boncy, Jacques Adrien, Paul François, Jeannot Jn Charles, Nadia Phaïmyr Blot, Valery Vanden Eng, Jodi L Priest, Jeffrey W Rogier, Eric Tohme, Rania A Open Forum Infect Dis Abstracts BACKGROUND: Measles, rubella, and maternal and neonatal tetanus have been verified to be eliminated in Haiti, but a diphtheria outbreak has been ongoing since 2014. To evaluate progress toward maintaining vaccine preventable disease (VPD) elimination and control, we conducted the first survey to estimate immunity to these VPDs among children in Haiti. METHODS: We conducted a nationally representative, two-stage cluster survey in 2017, stratifying Haiti into 2 regions: (1) West Region, the highly urban West department that includes one-third of Haiti’s population; (2) Non-West Region (all other departments). We sampled 4,286 households to recruit at least 910 children aged 5–7 years. We obtained vaccination history and dried blood spots from one eligible child per household. Antibody concentrations to VPDs were measured on a multiplex bead assay. We compared seroprotection and vaccination coverage estimates. RESULTS: Among 1146 enrolled children, tetanus (83%, 95% CI: 80%–86%) and diphtheria (83%, 95% CI: 81%–85%) seroprotection were higher than coverage with ≥3 doses of tetanus and diphtheria containing vaccine (DTP3) (68%, 95% CI: 61%–74%). No participants had antibody concentrations consistent with long-term immunity to tetanus or diphtheria. Measles (87%, 95% CI: 85%–89%) and rubella (84%, 95% CI: 81%–87%) seroprotection were higher than or similar to coverage with at least one dose of measles-rubella (MR) vaccine (84%, 95% CI: 80%–87%) (Figure 1). MR second-dose coverage was 20% (95% CI: 16%–24%). Seroprotection in the West Region was lower than in the non-West region for all VPDs. CONCLUSION: Discordance between DTP3 coverage and seroprotection might be due to underestimating vaccination coverage by recall. Lack of long-term protection against tetanus or diphtheria is consistent with declining antibody concentrations by school-age after the primary DTP series, indicating the need for a booster dose. Seroprotection against measles and rubella viruses was lower than levels needed to prevent transmission, particularly in the West region; re-introduction of either virus could lead to an epidemic. Haiti should reach ≥95% DTP3 and two-dose MR coverage and add tetanus and diphtheria vaccine booster doses per global recommendations. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810738/ http://dx.doi.org/10.1093/ofid/ofz360.2448 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Minta, Anna A
Andre-Alboth, Jocelyne
Childs, Lana
Nace, Doug
Rey-Benito, Gloria
Boncy, Jacques
Adrien, Paul
François, Jeannot
Jn Charles, Nadia Phaïmyr
Blot, Valery
Vanden Eng, Jodi L
Priest, Jeffrey W
Rogier, Eric
Tohme, Rania A
2771. Seroprotection against Measles, Rubella, Tetanus, and Diphtheria Among Children in Haiti—2017
title 2771. Seroprotection against Measles, Rubella, Tetanus, and Diphtheria Among Children in Haiti—2017
title_full 2771. Seroprotection against Measles, Rubella, Tetanus, and Diphtheria Among Children in Haiti—2017
title_fullStr 2771. Seroprotection against Measles, Rubella, Tetanus, and Diphtheria Among Children in Haiti—2017
title_full_unstemmed 2771. Seroprotection against Measles, Rubella, Tetanus, and Diphtheria Among Children in Haiti—2017
title_short 2771. Seroprotection against Measles, Rubella, Tetanus, and Diphtheria Among Children in Haiti—2017
title_sort 2771. seroprotection against measles, rubella, tetanus, and diphtheria among children in haiti—2017
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810738/
http://dx.doi.org/10.1093/ofid/ofz360.2448
work_keys_str_mv AT mintaannaa 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT andrealbothjocelyne 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT childslana 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT nacedoug 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT reybenitogloria 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT boncyjacques 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT adrienpaul 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT francoisjeannot 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT jncharlesnadiaphaimyr 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT blotvalery 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT vandenengjodil 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT priestjeffreyw 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT rogiereric 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017
AT tohmeraniaa 2771seroprotectionagainstmeaslesrubellatetanusanddiphtheriaamongchildreninhaiti2017